Scinai Immunotherapeutics (SCNI) Stock
Scinai Immunotherapeutics (SCNI) closed at $1.55 on Nov 19, 2026; its Tenet Score is 21 of 100 against 486 Healthcare peers.
Key stats
- Close
- $1.55
- Nov 19, 2026
- Market cap
- $10.2Munverified basis
- share basis not confirmed
- 52-week range
- 0.86 – 14.32
- low → high
- Tenet Score
- 21/100
- Weak · 486 Healthcare peers
Industry: Drugs · see every company filed here →
Scinai Immunotherapeutics Ltd. scores 21/100. Weak. Quality is the soft spot versus 486 Healthcare peers. Insufficient inputs: Tenet 21 is built from 2 of 4 pillars, from 45% of its inputs. The pillars showing a dash had no data, and Growth is left out because no growth rate could be measured.
Tenet Score · vs sector
n=486Factor grades
Value & Growth omitted — no data yet.
Price
Market cap: share price × the latest quarter's diluted weighted-average share count (vendor).
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Quality Compounder
- ✕ Drawdown Context
- ✕ Reversal Evidence
- ✕ Quality Floor
Holdings are on file. The share count they would be divided by is unverified, so the percentage is withheld.
BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company has licensing…
Common questions
What sector and industry is Scinai Immunotherapeutics in?
Scinai Immunotherapeutics is in the Healthcare sector and the Drugs industry.
What is Scinai Immunotherapeutics' Tenet Score?
Scinai Immunotherapeutics' Tenet Score is 21 out of 100, ranked against 486 Healthcare peers as of Nov 20, 2026.




